Furthermore, high-dose VC effectively blocked TGF-β1-induced breast cancer cell invasion as well as reversed the TGF-β1-induced downregulation of E-cadherin and upregulation of vimentin in these cells [182]. The gene discussed is TGFB1; the disease is breast carcinoma.